A BIOTECH company focused on utilising immunological approaches to diseases including dementia has been launched in Edinburgh.

Nodthera, launched by Epidarex Capital, is based on world class research conducted within Selvita, an international drug discovery company, with offices in Boston, San Francisco, Cambridge, UK and Krakow, Poland.